Envestnet Asset Management Inc Invitae Corp Transaction History

Envestnet Asset Management Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.42 - $0.72 $8,428 - $14,448	20,068 Added 17.32%	135,931 $85,000
Q3 2023 Nov 13, 2023	SELL	$0.6 - $1.53 $33,971 - $86,627	-56,619 Reduced 32.83%	115,863 $69,000
Q2 2023 Aug 04, 2023	BUY	$1.05 - $1.63 $123,676 - $191,992	117,787 Added 215.35%	172,482 $194,000
Q1 2023 May 11, 2023	SELL	$1.2 - $2.73 $20,182 - $45,915	-16,819 Reduced 23.52%	54,695 $73,000
Q4 2022 Feb 07, 2023	SELL	$1.71 - $3.61 $6,421 - $13,555	-3,755 Reduced 4.99%	71,514 $133,000

Q3 2022 Nov 10, 2022	BUY	$1.9 - $8.63 $8,333 - $37,851	4,386 Added 6.19%	75,269 $185,000
Q2 2022 Aug 03, 2022	BUY	$2.13 - $9.01 $15,218 - $64,376	7,145 Added 11.21%	70,883 $173,000
Q1 2022 May 04, 2022	BUY	$6.28 - $15.59 $19,442 - $48,266	3,096 Added 5.11%	63,738 $508,000
Q4 2021 Feb 04, 2022	SELL	$14.7 - $28.67 $126,890 - $247,479	-8,632 Reduced 12.46%	60,642 $926,000
Q3 2021 Oct 07, 2021	BUY	$24.31 - $33.6 $454,013 - $627,513	18,676 Added 36.91%	69,274 $1.97 Million
Q2 2021 Aug 04, 2021	SELL	$26.09 - $40.4 $60,346 - $93,445	-2,313 Reduced 4.37%	50,598 $1.71 Million
Q1 2021 May 04, 2021	BUY	$33.06 - $56.93 $744,742 - $1.28 Million	22,527 Added 74.14%	52,911 $2.02 Million
Q4 2020 Feb 02, 2021	BUY	$39.09 - $57.4 $730,240 - $1.07 Million	18,681 Added 159.63%	30,384 $1.27 Million
Q3 2020 Oct 09, 2020	BUY	$28.43 - $44.67 $112,099 - $176,133	3,943 Added 50.81%	11,703 $507,000
Q2 2020 Jul 08, 2020	BUY	$11.71 - $30.29 $90,869 - $235,050	7,760 New	7,760 $235,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.